This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

Findings demonstrate ATYR2810’s anti-tumor activity and increased survival in a model of glioblastoma multiforme (GBM), a primary form of brain cancer.

Abnormal kinase signaling can promote other harmful traits, such as neuroinflammation and neuronal cell death. On the other ...

Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced it will present preclinical data of FL-501 in a poster presentation ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

The FDA has granted approval to Akeso's differentiated programmed cell death protein 1 (PD-1) monoclonal antibody, penpulimab ...

• There is not enough evidence to determine the best method for preventing haemolytic uraemic syndrome (HUS) in patients with Shiga toxin-producing Escherichia coli (STEC)-associated diarrhoea. • More ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild ...

A monoclonal antibody (mAb) is a type of immune protein produced in a lab that binds to a specific protein on a cell (an antigen). As with naturally occurring antibodies, monoclonal antibodies ...

AMSBIO is helping to advance glycobiology research by supplying a trusted portfolio of high-affinity Heparan Sulfate (HS) monoclonal antibodies, now widely used in leading research laboratories ...